On-demand, at-home detection of biochemical health markers to
Telehealth is now widespread, but most routine testing still requires visits to a clinic or lab. This program is developing disruptive platform technologies to collect and analyze biological samples at home. This technology could revolutionize diagnostics, chronic disease management, and even clinical research, providing better access to care and a more disaster-resilient health care system.
Companies we have partnered with on this program to date
Support the development and validation of new platform technologies for simple, rapid multiplexed analysis of biological specimens in the home setting.
Technologies that enable more rapid delivery of healthcare
Platform technologies that are adaptable to a broad menu of multiplex test panels
Routine health care practice is available to all, especially when coupled with telemedicine
Lab at Home is open until February 6, 2024